Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest The Texas Heart Institute Stories

2012-03-26 10:05:06

Cell therapy may present an option for patients with ischemic heart disease to use their own bone marrow cells to repair the damaged areas of their hearts, and may pave the way for future treatment options, according to the FOCUS trial, which will be presented as a late-breaking clinical trial March 24 at the 61st annual American College of Cardiology (ACC) scientific session. This is the largest study to date to look at stem cell therapy, using a patient's own stem cells, to repair...

2012-03-12 21:25:02

Some patients with advanced heart failure caused by cardiomyopathy, the deterioration of function of the heart muscle, are getting a new lease on life thanks to an innovative treatment program at Jewish Hospital, a part of KentuckyOne Health, and the University of Louisville. Led by Emma Birks, M.D., Ph.D., FRCP, director of the Jewish Hospital Heart Failure, Transplant and Mechanical Support Program, the program treats advanced heart failure patients who have left ventricular assist...

2012-02-28 14:00:00

For heart failure patients with end stage disease, mechanical assist devices can take over the heart's pumping function and improve blood flow and organ function. Abington, PA (PRWEB) February 28, 2012 The Pilla Heart Center at Abington Memorial Hospital is now offering ventricular assist device (VAD) therapy for patients with end-stage heart failure. The VAD, also referred to as a mechanical assist device, is recommended when the heart fails to respond to other interventions such as...

2012-02-23 13:25:00

Total Artificial Heart Available at 56 SynCardia Certified Centers Worldwide with an Additional 34 Hospitals Currently Undergoing Certification Tucson, AZ (PRWEB) February 23, 2012 SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the 1,000th implant of the world´s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart was performed on Feb. 10 at The University of Arizona Medical Center in Tucson,...

2012-02-23 07:05:00

TUCSON, Ariz., Feb. 23, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the SynCardia temporary Total Artificial Heart, announced today that the 1,000th implant of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart was performed on Feb. 10 at The University of Arizona Medical Center in Tucson, AZ. Since then, an additional four implants of the Total Artificial Heart have been performed at SynCardia Certified Centers...

2012-02-15 13:09:00

DETROIT, Feb. 15, 2012 /PRNewswire-USNewswire/ -- Few hospitals have as much experience with the Berlin Heart as DMC Children's Hospital of Michigan. This is why the U.S. Food and Drug Administration (FDA) was eager to hear testimony from Henry L. Walters III, MD, chief of cardiovascular surgery at DMC Children's Hospital of Michigan. Dr. Walters provided testimony about the device at a recent public hearing. After reviewing the clinical trial data and hearing testimony from Dr. Walters and...

2012-01-25 05:33:00

LA JOLLA, Calif., Jan. 25, 2012 /PRNewswire/ -- Interest in adult stem cell therapies and their clinical applicability in treating and helping patients is growing, while accurate information remains difficult to access. Cell Society International, a nonprofit organization, is dedicated to advancing the clinical applications of adult stem cell therapies worldwide through education and the collaboration of world thought leaders. According to Emerson C. Perin, MD, PhD, Director, Clinical...

2012-01-04 21:00:00

SynCardia Profitable for 1st Time in Company´s 10-Year History Tucson, AZ (PRWEB) January 04, 2012 SynCardia Systems, Inc., manufacturer of the world´s only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that in 2011, the company nearly doubled sales for the second straight year, representing a four-fold increase since 2009. “This is the first full year that SynCardia has been profitable during the company´s 10-year history,”...

2012-01-04 11:51:00

TUCSON, Ariz., Jan. 4, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that in 2011, the company nearly doubled sales for the second straight year, representing a four-fold increase since 2009. (Photo: http://photos.prnewswire.com/prnh/20120104/LA29865) "This is the first full year that SynCardia has been profitable during the company's...